The development and introduction of anti-oxytocic tocolytics

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 110, Issue SUPPL. 20, 2003, Pages 108-112

  Lamont, Ronald F ^a  

^a ST MARK S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ATOSIBAN; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; OXYTOCIN; OXYTOCIN DERIVATIVE; RITODRINE; UTERUS SPASMOLYTIC AGENT; VASOPRESSIN;

BREAST DISEASE; CARDIOVASCULAR SYMPTOM; CLINICAL TRIAL; CONFERENCE PAPER; DRUG EFFECT; DRUG MECHANISM; DRUG POTENCY; DYSMENORRHEA; EXPERIMENTAL MODEL; HUMAN; INHIBITION KINETICS; LABOR; MYOMETRIUM; NONHUMAN; PREMATURE LABOR; PRIORITY JOURNAL; UTERUS CONTRACTILITY; UTERUS CONTRACTION;

CLINICAL TRIALS, PHASE II; DOUBLE-BLIND METHOD; DRUG DESIGN; FEMALE; HUMANS; OBSTETRIC LABOR, PREMATURE; OXYTOCICS; PREGNANCY; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS; TOCOLYTIC AGENTS; VASOTOCIN;

EID: 0038664205     PISSN: 14700328     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-0328(03)00055-7     Document Type: Conference Paper

References (27)

1. Lamont R.F. The pathophysiology of pulmonary oedema with the use of beta-agonists. Br J Obstet Gynaecol. 107:2000;439-444.
2. Beta-agonists for the care of women in labour. Guideline No. 1. 1997;RCOG Press, London.
3. Besinger R.E., Iannucci T.A. Tocolytic therapy. Elder M.G., Romero R., Lamont R.F. Preterm Labour. 1997;243-297 Churchill Livingstone, New York.
4. Fuchs A-R, Fuchs F., Husslein P., Soloff M.S., Fernstrom M.J. Oxytocin receptors and human parturition: a dual role for oxytocin in the initiative of labor. Science. 215:1982;1396-1398.
5. Fuchs A-R, Behrens O., Liu H.C. Correlation of nocturnal increase in plasma oxytocin with a decrease in plasma estradiol/progesterone ratio in late pregnancy. Am J Obstet Gynecol. 167:1992;159-163.
6. Melin P. Development of an oxytocin antagonist - Atosiban. Res Clin Forums. 16:1994;155-170.
7. Chibbar R., Miler F.C., Mitchell B.F. Synthesis of oxytocin in amnion, chorion and decidua may influence the timing of human parturition. J Clin Invest. 91:1993;185-192.
8. Fuchs A.R., Fuchs F. Endocrinology of human parturition: a review. Br J Obstet Gynaecol. 91:1984;948-967.
9. Du Vigneaud V., Ressler C., Trippett S. The sequence of amino acids in oxytocin, with a proposal for the structure of oxytocin. J Biol Chem. 205:1953;949-957.
10. Law H.D., du Vigneaud V. Synthesis of 2p-methoxyphenylalanine oxytocin (O-Methyl-oxytocin) and some observations on its pharmacological behaviour. J Am Chem Soc. 82:1960;4579-4581.
11. Melin P., Vilhardt H., Lindeberg G., Larsson L-E, Akerlund M. Inhibitory effect of O-alkylated analogues of oxytocin and vasopressin on human and rat myometrial activity. J Endocrinol. 88:1981;173-180.
12. Akerlund M., Stromberg P., Forsling M.L., Melin P., Vilhardt H. Inhibition of vasopressin effects on the uterus by a synthetic analogue. Obstet Gynecol. 62:1983;309-312.
13. Melin P., Trojnar J., Vilhardt H., Akerlund M. Uterotonic oxytocin and vasopressin antagonists with minimal structure modifications. Hruby V.J., Rich D.H. Peptides: Structure and Function Proceedings of the 8th American Peptide Symposium. 1983;361-365 Pierce Chemical, Rockford, USA.
14. Melin P., Trojnar J., Johansson B., Vilhardt H., Åkerlund M. Synthetic anatagonists of the myometrial response to vasopressin and oxytocin. J Endocrinol. 111:1986;125-131.
15. Akerlund M., Carlsson A.M., Melin P., Trojnar J. The effect on the human uterus of two newly developed competitive inhibitors of oxytocin and vasopressin. Acta Obstet Gynecol Scand. 64:1985;499-504.
16. Åkerlund M. Oxytocin antagonists in the treatment of preterm labour. Fet Mat Med Rev. 13:2002;31-41.
17. Lamont R.F., Greenfield P. Anti-oxytocic tocolytic agents. Yearbook of the Royal College of Obstetricians and Gynaecologists. 10:2002;30-140 RCOG Press, London.
18. Phaneuf S., Asboth G., Mackenzie I.Z., Melin P., Lopez-Bernal A. Effect of oxytocin antagonists on the activation of human myometrium in vitro: Atosiban prevents oxytocin-induced desensitisation. Am J Obstet Gynecol. 171:1994;1626-1634.
19. Akerlund M., Stromberg P., Hauksson Aet al. Inhibition of uterine contractions of premature labour with an oxytocin analogue. Results from a pilot study. Br J Obstet Gynaecol. 94:1987;1040-1044.
20. Andersen L-F, Lyndrup J., Akerlund M., Melin P. Oxytocin receptor blockade: a new principle in the treatment of preterm labour. Am J Perinatol. 6:1989;196-199.
21. Treatment of preterm labor with the beta-adrenergic agonist ritodrine. N Engl J Med. 327:1992;308-312.
22. King J., Grant A., Keirse M.J., Chalmers I. Beta-mimetics in preterm labor: an overview of the randomized controlled trials. Br J Obstet Gynaecol. 95:1988;211-222.
23. Goodwin T.M., Paul R.P., Silver Het al. The effect of the oxytocin antagonist atosiban on preterm uterine activity in the human. Am J Obstet Gynecol. 170:1994;474-478.
24. Goodwin T.M., Valenzuela G.J., Silver H., Creasy G. Dose ranging study of the antagonist atosiban in the treatment of preterm labor. Obstet Gynecol. 88:1996;331-336.
25. Romero R., Sibai B.M., Sanchez-Ramos Let al. An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: a randomized, double-blind, placebo-controlled trial with tocolytic rescue. Am J Obstet Gynecol. 182:2000;1173-1183.
26. Valenzuela G.J., Sanchez-Ramos L., Romero Ret al. Maintenance treatment of preterm labor with the oxytocin antagonist atosiban. Am J Obstet Gynecol. 182:2000;1184-1190.
27. Effectiveness and safety of the oxytocin antagonist Atosiban versus beta-adrenergic agents in the treatment of preterm labour. Br J Obstet Gynaecol. 108:2001;133-142.